Molecular Imaging World Summit 2019

Molecular Imaging World Summit 2019

MI—the gateway to precision medicine

Thursday, May 16-Saturday, May 18
Lausanne, Switzerland

Hosted by Siemens Healthineers, the Molecular Imaging World Summit 2019 brought together over 240 participants from more than 140 institutions around the world. Featuring 45 speakers, the two-day program included individual talks and panel discussions around the need for quantification and MI’s unique contribution to early diagnosis, planning, and therapy management. A closing session explored possibilities for progressing PET and SPECT imaging. Fueled by optimism for the future, the Summit fostered lively discussion around opportunities for molecular imaging and the field’s significance in the expansion of personalized care.

MI Clinical Corner

Gallery

Scientific Presentations

Prof. John O. Prior, Centre Hospitalier Universitaire Vaudois (Switzerland)

Prof. David Townsend (Ret.), Singapore Clinical Imaging Research Centre (Canada)

Utilizing PET/CT quantification in clinical routine

Prof. Richard Wahl, Washington University School of Medicine (USA)

Prof. Nicolas Aide, CHU de Caen (France)

Defining thresholds for quantitative SPECT/CT imaging: clinically what is needed and next steps

Panel discussion moderated by Prof. Dale Bailey,
Royal North Shore Hospital (Australia)
Panelists:
Priv.-Doz. Dr. Guido Böning, Ludwig-Maximilians-Universität München (Germany)
Prof. Jun Hatazawa, Osaka University (Japan)
Prof. Homer A. Macapinlac, University of Texas MD Anderson Cancer Center (USA)
Prof. John O. Prior, Centre HospitalierUniversitaireVaudois (Switzerland)

Multiparametric PET—the future?

Panel discussion moderated by Dr. Richard E. Carson, Yale University (USA)
Panelists:
Prof. Ronald Borra, University of Groningen, University Medical Center
Groningen (The Netherlands)
Dr. Dustin Osborne, University of Tennessee Graduate School of Medicine (USA)
Dr. Anne M. Smith, Molecular Imaging, Siemens Healthineers (USA)
Prof. Richard Wahl, Washington University School of Medicine (USA)

Dr. Val J. Lowe, Mayo Clinic (USA)

Prof. Jun Hatazawa, Osaka University (Japan)

Dr. Helmut Rasch, Kantonsspital Baselland (Switzerland)

Dr. Iain Duncan, Garran Medical Imaging (Australia)

Drs. Human Adams, Green Heart Hospital (The Netherlands)

Prof. Damian Wild, Universitätsspital Basel (Switzerland)

Early detection and treatment of cardiovascular disease: the future and what’s needed

Dr. Venkatesh Murthy, University of Michigan, Ann Arbor (USA)

Biograph Vision—clinical experience and potential

Panel discussion moderated by Dr. Daniel A. Pryma,
University of Pennsylvania Perelman School of Medicine (USA)
Panelists:
Dr. Walter Noordzij, University of Groningen,
University Medical Center Groningen (The Netherlands)
Prof. John O. Prior, Centre HospitalierUniversitaireVaudois (Switzerland)
Prof. Pierre-Yves Salaün, University Hospital Brest (France)

Prof. Elba Cristina Sá de Camargo Etchebehere, The University of Campinas and grupoMND (Brazil)

Prof. Rodney Hicks, Peter MacCallum Cancer Centre (Australia)

Bringing nuclear medicine to patients
An industry perspective

Dr. Germo Gericke, Advanced Accelerator Applications, A Novartis Company (Switzerland)

Prof. Dr. Alexander Drzezga, UniklinikKöln (Germany)

Quantitative SPECT/CT imaging for therapies: from response assessment to dose tailoring today and beyond

Panel discussion moderated by Prof. Dale Bailey, Royal North Shore Hospital (Australia)
Panelists:
Prof. Dr. Peter Bartenstein, Ludwig-Maximilians-Universität München (Germany)
Dr. Jean-Mathieu Beauregard, CHU de Québec -UniversitéLaval (Canada)
Dr. Germo Gericke, Advanced Accelerator Applications, A Novartis Company (Switzerland)
Prof. Rodney Hicks, Peter MacCallum Cancer Centre (Australia)
Prof. Niklaus Schaefer, Centre HospitalierUniversitaireVaudois (Switzerland)
Prof. Damian Wild, UniversitätsspitalBasel (Switzerland)

Prof. Olivier Michielin, Centre Hospitalier Universitaire Vaudois (Switzerland)

PET imaging for immunotherapy

Prof. Wolfgang A. Weber, Technische Universität München (Germany)

Shanghai Zhongshan Hospital Nuclear Medicine Department A glimpse into molecular imaging development in China

Prof. Dr. Shi Hongcheng, Zhongshan Hospital, Fudan University (China)

Prof. Nagara Tamaki, KyotoPrefecturalUniversityofMedicine (Japan)
Dr. Bernard Bendriem, Molecular Imaging, Siemens Healthineers (USA)

Prof. Dr. Klaus Schäfers, Universitätsklinikum Münster (Germany)
Paul Schleyer, Molecular Imaging, Siemens Healthineers (USA)

Prof. Dr. F. L. Giesel, University Hospital Heidelberg (Germany)

Considerations for quantitative cardiac SPECT/CT and
coronary CTA/CT-FFR

Dr. Venkatesh Murthy, University of Michigan, Ann Arbor (USA)
Alexander Hans Vija, Molecular Imaging, Siemens Healthineers (USA)

Opportunities for AI in molecular imaging

Univ.-Prof. Dr. Marcus Hacker, MedizinischenUniversität Wien (Austria)
Sven Zuehlsdorff, Molecular Imaging, Siemens Healthineers (USA)

Prof. Martin Alexander Walter, Hôpitaux Universitaires de Genève (Switzerland)